# clm_EB2A23BDB86D

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_net_income  
value: 842,100,000 United States dollar  
valid_from: 2020-09-30  
valid_to: 2021-03-31  
published: 2020-11-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_C9912D8698CC  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly net income: 842,100,000 United States dollar", as of 2020-09-30 (until 2021-03-31). Claim clm_EB2A23BDB86D, https://asof.is/claim/clm_EB2A23BDB86D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422020000030/0001804220-20-000030-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q3 FY2020, filed 2020-11-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000180422020000030/0001804220-20-000030-index.htm (primary, SEC EDGAR 10-Q Q3 FY2020, published 2020-11-05)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 897,300,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_EB2A23BDB86D](/claim/clm_EB2A23BDB86D.md) | [clm_A816A2A4556B](/claim/clm_A816A2A4556B.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.